First women's HIV conference hears go-for-broke antiretroviral strategy.
Mascolini
M
M
D000935:Antifungal Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D003376:Counseling; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission; D006266:Health Education; D006801:Humans; D018445:Infectious Disease Transmission, Vertical; D009181:Mycoses / Q000150:complications / Q000517:prevention & control; D010146:Pain / Q000150:complications / Q000188:drug therapy; D010818:Practice Patterns, Physicians'; D011247:Pregnancy; D015215:Zidovudine / Q000627:therapeutic use
D000935:Antifungal Agents; D000998:Antiviral Agents; D015215:Zidovudine; D015725:Fluconazole